Intellectia LogoIntellectia
Product
Resources
Stock
Crypto
Pricing
Sign inTry for Free
Intellectia Logo
Sign in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
AI Screener
Trading Strategy
AI Stock Picker
Swing Trading
Earnings Trading
Stock Chart Patterns

Resources

Learn
Blog
Earnings
Tutorial
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
StockCryptoPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. BHVN
    4. >
  4. Forecast

Stock Price Prediction

-
stocks logo
BHVN
-
$
0.000
0.000(0.000%)
    OverviewForecastTechnicalOptionsEarningsFinancialsValuationInsiders

BHVN Similar Chart Price Prediction

The price of BHVN is predicted to go up -6.95%, based on the high correlation periods with CHRW. The similarity of these two price pattern on the periods is 90.51%.

stocks logo

BHVN

stocks logo

CHRW

Down: -6.95%Similarity: 90.51%

BHVN Revenue Forecast

BHVN EPS Forecast

BHVN FAQs

What is bull’s view on BHVN?

Bulls view BHVN as undervalued with strong upside potential, supported by a $59 price target from HC Wainwright and $61 from RBC Capital, implying a 53% and 31% upside, respectively. The optimism stems from its promising drug pipeline, including Troriluzole for spinocerebellar ataxia, which has shown positive Phase 3 results and could launch in late 2025. Additionally, its oversold RSI of 29.8 suggests a potential rebound from recent lows near $35.

What is bear's view on BHVN?

Bears view BHVN stock negatively due to its recent legal issues, including a $60M settlement for Medicare false claims, which could harm its reputation and financials. The stock is trading at $39.33, down 3.39%, reflecting investor concerns about potential regulatory scrutiny and operational risks. Additionally, the missed Phase 3 trial endpoint for taldefgrobep in SMA adds to uncertainty about its pipeline success.

What is BHVN revenue forecast for next quarter？

The market consensus for BHVN's revenue in the upcoming quarter is projected to be approximately $2.5M USD.

BHVN VS S&P500

Ask Intellectia about BHVN

BHVN Analyst's Forecast

David Hoang

Deutsche Bank

Strong Buy

2025-02-11

Price Target

$65

Upside

+50.32%

Deutsche Bank initiated coverage of Biohaven with a Buy rating and $65 price target.
Leonid Timashev

RBC Capital

Buy

2024-12-04

Price Target

$58 → $61

Upside

+31.49%

Leonid Timashev

RBC Capital

Buy

2024-11-25

Price Target

$66 → $58

Upside

+27.42%

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerCrypto Technical AnalysisAI Screener
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings Trading
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySitemap
Start for Free

Hot Stocks

stocks logo

OGS

ONE Gas Inc

$74.79
0.20%
stocks logo

KGS

Kodiak Gas Services Inc

$43
2.31%
stocks logo

GVA

Granite Construction Inc

$82.17
0.33%
stocks logo

GBDC

Golub Capital Bdc Inc

$15.56
-0.83%
stocks logo

OGN

Organon & Co

$15.48
-4.03%
stocks logo

SIM

Grupo Simec SAB de CV

$26.4
0.30%
stocks logo

CRGY

Crescent Energy Co

$13.47
-1.61%
stocks logo

NOG

Northern Oil and Gas Inc

$32.08
-0.34%
stocks logo

CORZ

Core Scientific Inc

$10.02
2.66%
stocks logo

SRRK

Scholar Rock Holding Corp

$37.02
1.84%